Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT06726941
Recruiting Not applicable

Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia

NCT06726941 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-20
Last updated
2025-11-25

Condition(s) studied

Ischemic Stroke, AcuteAcute Hemiparesis

Investigational drug(s) / intervention(s)

Physiotherapy and Rehabilitation Practices

Physiotherapy and Rehabilitation Practices: It was planned to give the participants a routine stroke rehabilitation program consisting of 45 minutes of active, passive range of motion exercises and strengthening exercises, balance exercises, walking training and 20 minutes of bicycle ergometry, accompanied by a physiotherapist with at least 5 years of experience in stroke rehabilitation. It was planned to give passive bicycle ergometry to patients without voluntary muscle movement and muscle strength, and active bicycle ergometry to participants with voluntary muscle movement and muscle strength, with the bicycle rehabilitation. It was planned to apply the exercise program to the patients for 5 days a week and for a total of 30 sessions. It will be recommended that they continue the medical treatment they are using during the treatment program. Routine evaluations will be made by the physiatrist before the rehabilitation program starts and 2 tubes of venous blood will be taken from the patients by an experienced nurse

Study summary

The aim of this study is to demonstrate the effect of routine exercise program on neuroplasticity through histone acetylation and gene expression changes in acute stroke survivors from an epigenetic perspective and to investigate the correlation of epigenetic effects with its effects on motor function and quality of life.

Eligibility

Sex
ALL
Min age
25 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. Participants who applied to Afyonkarahisar Health Sciences University Physical Therapy and Rehabilitation Clinic for rehabilitation purposes and had a stroke for the first time 2. Participants with ischemia as the etiology of stroke 3. Participants between the ages of 25-70 4. Drugs that have been used for at least 1 month and up to 6 months after a cerebrovascular accident Exclusion Criteria: 1. Participants whose stroke etiology is other than ischemia 2. Participants with clinically significant neurological disease other than stroke 3. Participants with systemic and musculoskeletal diseases that will not tolerate neurological rehabilitation and prevent them from participating

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Afyonkarahisar Health Sciences University Afyonkarahisar Turkey (Türkiye) Recruiting

More Afyonkarahisar Health Sciences University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06726941 on ClinicalTrials.gov ↗ ← All trials in Turkey